Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1992 5
1993 3
1994 3
1995 3
1997 6
1998 4
1999 1
2000 7
2001 3
2002 4
2003 5
2004 10
2005 11
2006 10
2007 6
2008 7
2009 12
2010 13
2011 15
2012 15
2013 17
2014 15
2015 17
2016 12
2017 16
2018 9
2019 20
2020 21
2021 21
2022 12
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Evolving therapies for myocardial ischemia/reperfusion injury.
Ibáñez B, Heusch G, Ovize M, Van de Werf F. Ibáñez B, et al. Among authors: ovize m. J Am Coll Cardiol. 2015 Apr 14;65(14):1454-71. doi: 10.1016/j.jacc.2015.02.032. J Am Coll Cardiol. 2015. PMID: 25857912 Free article. Review.
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.
Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D; CARDIOPROTECTION COST Action (CA16225). Davidson SM, et al. Among authors: ovize m. J Am Coll Cardiol. 2019 Jan 8;73(1):89-99. doi: 10.1016/j.jacc.2018.09.086. J Am Coll Cardiol. 2019. PMID: 30621955 Free article. Review.
Reduced reticulum-mitochondria Ca2+ transfer is an early and reversible trigger of mitochondrial dysfunctions in diabetic cardiomyopathy.
Dia M, Gomez L, Thibault H, Tessier N, Leon C, Chouabe C, Ducreux S, Gallo-Bona N, Tubbs E, Bendridi N, Chanon S, Leray A, Belmudes L, Couté Y, Kurdi M, Ovize M, Rieusset J, Paillard M. Dia M, et al. Among authors: ovize m. Basic Res Cardiol. 2020 Nov 30;115(6):74. doi: 10.1007/s00395-020-00835-7. Basic Res Cardiol. 2020. PMID: 33258101 Free PMC article.
Postconditioning in man.
Thibault H, Piot C, Ovize M. Thibault H, et al. Among authors: ovize m. Heart Fail Rev. 2007 Dec;12(3-4):245-8. doi: 10.1007/s10741-007-9033-2. Heart Fail Rev. 2007. PMID: 17522975 Review.
An Update on the Multifaceted Roles of STAT3 in the Heart.
Harhous Z, Booz GW, Ovize M, Bidaux G, Kurdi M. Harhous Z, et al. Among authors: ovize m. Front Cardiovasc Med. 2019 Oct 25;6:150. doi: 10.3389/fcvm.2019.00150. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31709266 Free PMC article. Review.
Postconditioning: from the bench to bedside.
Cour M, Gomez L, Mewton N, Ovize M, Argaud L. Cour M, et al. Among authors: ovize m. J Cardiovasc Pharmacol Ther. 2011 Jun;16(2):117-30. doi: 10.1177/1074248410383174. Epub 2010 Oct 11. J Cardiovasc Pharmacol Ther. 2011. PMID: 20938041 Review.
Novel therapeutic strategies for cardioprotection.
Sluijter JP, Condorelli G, Davidson SM, Engel FB, Ferdinandy P, Hausenloy DJ, Lecour S, Madonna R, Ovize M, Ruiz-Meana M, Schulz R, Van Laake LW; Nucleus of the European Society of Cardiology Working Group Cellular Biology of the Heart. Sluijter JP, et al. Among authors: ovize m. Pharmacol Ther. 2014 Oct;144(1):60-70. doi: 10.1016/j.pharmthera.2014.05.005. Epub 2014 May 13. Pharmacol Ther. 2014. PMID: 24837132 Review.
Postconditioning in acute myocardial infarction patients.
Ivanes F, Rioufol G, Piot C, Ovize M. Ivanes F, et al. Among authors: ovize m. Antioxid Redox Signal. 2011 Mar 1;14(5):811-20. doi: 10.1089/ars.2010.3354. Epub 2010 Oct 6. Antioxid Redox Signal. 2011. PMID: 20578963 Review.
275 results